There can be little doubt that immunotherapy has been one of the great advances in cancer treatment of the past 25 years. And while there

As we continue our series on prostate cancer, we must address the subject that is most controversial about prostate cancer, i.e., the utility of screening.

As I noted last week, I have not written much about prostate cancer as I find the information and data about this cancer difficult to

Readers of this column may realize that I seldom write about prostate cancer despite its enormous incidence and consequences in men. In part, this stems

This past week, a close friend, Jesse Cogan, passed away. He was a dynamo in high school, went to YU, excelled in the public relations

As the child of Holocaust survivors, I do not have many relatives. My half-sister, grandparents, multiple aunts and uncles were all killed in Europe and

A lot of attention was recently aroused by the plans of the Biden administration to put health warning labels on liquor bottles to reflect the

Last week we reviewed the origins and rationale for the Long Island Breast Cancer Study. Per the dictates of the congressional bill that funded us,

I have not often made reference in these articles to studies in which I participated, but one such study, the Long Island Breast Cancer Study,

For those who engage in Daf Yomi, the daily study of a page of the Talmud, a major milestone was achieved last week when the

We have reported any number of times before in this column that, while cancers of the lower gastrointestinal tract are more common in countries of